“A vaccine is a more important development for the economy and markets than the prospective policies of a Biden presidency,” David Kostin wrote, in the very first line of Goldman’s 2021 US equity outlook entitled “Roaring ’20s Redux.” For Kostin, Pfizer’s vaccine (or really just a vaccine) should “allow society … Continue reading Goldman Sees ‘Roaring ‘20s Redux.’ S&P To Hit 4,600 In 2022